GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Exam Corner/Dyssynergic Defecation
33

Dyssynergic Defecation

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated October 1, 2025

Dyssynergic Defecation (DD): Comprehensive Overview

Definition and Prevalence

Dyssynergic defecation (DD) is a common subtype of chronic constipation, accounting for up to 50% of cases. It is characterized by impaired coordination between rectal propulsion and pelvic floor relaxation during defecation. Essentially, the muscles involved in the process of defecation fail to work in harmony, leading to difficulty in evacuating stool.


Pathophysiology

Successful defecation requires synchronized activity of multiple processes:

  1. Rectal Pressure Generation: The rectum must generate sufficient pressure to propel stool.

  2. Pelvic Floor Relaxation: The pelvic floor muscles and anal sphincter must relax to allow stool passage.

  3. Anorectal Descent and Angle Widening: The anorectal region must descend and widen to facilitate evacuation.

In DD, these processes are disrupted, often due to spastic pelvic floor dysfunction, which is the dominant abnormal phenotype in affected individuals.


Diagnostic Challenges

Traditional diagnostic tools like high-resolution anorectal manometry (HR-ARM), balloon expulsion test (BET), and defecography are often performed separately and in different body positions. This reduces their ability to assess real-time coordination during defecation. As a result, diagnosing DD has been challenging.


Advances in Diagnosis: Proctomanometry

A prospective study involving 120 participants (60 healthy, 60 constipated) introduced synchronous proctomanometry, a combined method that simultaneously measures:

  • Anorectal pressures
  • Pelvic motion
  • Evacuation dynamics

Proctomanometry demonstrated superior diagnostic accuracy compared to HR-ARM, especially in assessing real-time defecatory physiology. It provides a comprehensive understanding of the coordination required for successful defecation.


Key Findings from the Study

  1. Evacuation Success Rates:
  • 86% of healthy participants successfully evacuated ≥25% of rectal content.
  • Only 45% of constipated patients achieved this, confirming impaired evacuation in DD.
  1. Balloon Expulsion Test (BET):
  • BET times were significantly shorter in participants who could evacuate (31 ± 56 seconds) compared to those who could not (126 ± 76 seconds).
  • BET showed a strong negative correlation with rectal evacuation (r = –0.59; P < 0.001).
  1. Defecation Sequence:
  • During the preparatory phase, rectal and anal pressures rose simultaneously.
  • Anorectal descent and angle widening followed, precursors to successful evacuation.
  • Evacuation began only when rectal pressure exceeded anal pressure, creating a positive rectoanal gradient, a critical marker of functional coordination.
  1. Evacuation Physiology:
  • Higher rectal pressures, larger rectoanal gradients, greater anorectal descent, and wider angle changes were observed in evacuators compared to nonevacuators (P ≤ 0.001).
  1. Gender Differences:
  • Men generated higher rectal pressures but showed less anorectal descent than women (P ≤ 0.04), suggesting sex-based mechanical differences in defecation.

Physiological Phenotypes

The study identified four distinct defecatory phenotypes:

  1. Balanced Evacuation: Normal pressure and motion; 100% evacuators.

  2. High-Pressure Evacuation: Elevated rectal pressures with reduced anorectal descent; 84% evacuators.

  3. Low-Pressure Evacuation: Low rectal pressures but moderate evacuation; 85% evacuators.

  4. Spastic Pelvic Floor: Minimal anorectal motion and poor evacuation; 94% nonevacuators.

Dominant Phenotype:

  • 78% of DD patients fell into the "spastic pelvic floor" category, indicating a combination of propulsion and relaxation dysfunction.

Structural Findings

Structural abnormalities were relatively uncommon but notable:

  • Rectoceles (>1 cm): Found in 30% of women and correlated with higher evacuation pressures (P = 0.02).
  • Enteroceles: Present in 6%.
  • Intussusception: Observed in 10%.

These structural defects may contribute to evacuation difficulties in some patients.


Therapeutic Implications

  1. Pelvic Floor Physical Therapy:
  • Physical therapy targeting pelvic floor relaxation significantly improved symptoms (CRADI-8: –12.3; P = 0.009).
  • It also reduced anal electromyography activity (P < 0.001), validating its therapeutic potential.
  1. Biofeedback Therapy:
  • Proctomanometry provides detailed insights into defecatory physiology, enabling personalized biofeedback therapy to retrain muscle coordination and improve evacuation.

Clinical Conclusion

Successful defecation depends on synchronized rectal pressure generation, anorectal descent, and angle widening. Proctomanometry offers a more accurate diagnostic tool compared to traditional methods, allowing for targeted interventions such as biofeedback therapy or physical therapy. This approach holds promise for improving management and outcomes in patients with dyssynergic defecation.

Related Q&A

34

Chicago Classification v4.0 Update

The Chicago Classification v4.0 (CCv4.0) is the latest update in the diagnostic framework for interpreting high-resolution esophageal manometry (HRM), a tool used to evaluate esophageal motility disorders. This...

35

Ervogastat and Clesacostat in stage II-III MASH

Ervogastat and Clesacostat in Stage II–III MASH: Detailed Overview Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of fatty liver disease characterized by inflammation, liver cell injury, and...

36

Dopaminergic Signalling

Dopaminergic Signalling refers to the biological processes mediated by the neurotransmitter dopamine, a key chemical messenger in the body. Dopamine is involved in transmitting signals between neurons and...

37

Intestinal pH

Intestinal pH refers to the level of acidity or alkalinity within the gastrointestinal (GI) tract, which plays a critical role in regulating the composition and metabolic activity of...

38

Linaclotide vs Plecanatide

Linaclotide and Plecanatide are both guanylate cyclase-C (GC-C) agonists approved by the U.S. FDA for the treatment of chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation...

39

K-Ras

K-Ras: A Comprehensive Overview --- What is K-Ras? K-Ras (Kirsten Rat Sarcoma viral oncogene homolog) is a proto-oncogene that encodes a small GTPase protein in the RAS family....

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer